PhRMA on drug samples:
According to Johnson, restricting the free samples given to doctors would be “unfortunate and could negatively affect patients who rely upon the $16 billion worth of medicines distributed each year,” which “often serve as a safety net.” He added, “We believe that pharmaceutical companies should not offer or provide anything to doctors that would interfere with the independence of their prescribing practices,” but, “[c]learly, pharmaceutical marketing benefits patients.”
ADVERTISEMENT
Get free updates delivered free to your inbox.
Search thousands of physician, PA, NP, and CRNA jobs now.
Comments are moderated before they are published. Please read the comment policy.
